-
1
-
-
0038204638
-
Pathogenesis of HIV-associated heart disease
-
Barbaro G. Pathogenesis of HIV-associated heart disease. AIDS. 2003; 17: S12-20.
-
(2003)
AIDS
, vol.17
-
-
Barbaro, G.1
-
2
-
-
0037869544
-
HIV and cardiovascular medicine
-
Prendergast BD. HIV and cardiovascular medicine. Heart. 2003; 89: 793-800.
-
(2003)
Heart
, vol.89
, pp. 793-800
-
-
Prendergast, B.D.1
-
3
-
-
0034896962
-
Cardiovascular manifestations of HIV infection
-
Barbaro G. Cardiovascular manifestations of HIV infection. J R Soc Med. 2001; 94: 384-90.
-
(2001)
J R Soc Med
, vol.94
, pp. 384-390
-
-
Barbaro, G.1
-
4
-
-
0035800026
-
Highly active antiretroviral therapy decrease mortality and morbidity in patients with advanced HIV disease
-
Murphy El, Collier AC, Kalish LA. Highly active antiretroviral therapy decrease mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001; 135: 17-26.
-
(2001)
Ann Intern Med
, vol.135
, pp. 17-26
-
-
Murphy, E.1
Collier, A.C.2
Kalish, L.A.3
-
5
-
-
33846023702
-
Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria
-
Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria. Diabetes Care. 2007; 30: 113-9.
-
(2007)
Diabetes Care
, vol.30
, pp. 113-119
-
-
Samaras, K.1
Wand, H.2
Law, M.3
Emery, S.4
Cooper, D.5
Carr, A.6
-
6
-
-
0028232001
-
Plasma lipids in HIV-infected patients: A prospective study in 95 patients
-
Constant J, Pellegrin Jl, Peuchant E. Plasma lipids in HIV-infected patients: a prospective study in 95 patients. Eur J Clin Invest. 1994; 24: 416-20.
-
(1994)
Eur J Clin Invest
, vol.24
, pp. 416-420
-
-
Constant, J.1
Pellegrin, J.2
Peuchant, E.3
-
7
-
-
0345064200
-
Combination antiretroviral therapy and the risk of myocardial infarction
-
The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
-
The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003; 349: 1993-2003.
-
(2003)
N Engl J Med
, vol.349
, pp. 1993-2003
-
-
-
8
-
-
17144463863
-
Severe premature coronary artery disease with protease inhibitors
-
Henry K, Melroe H, Huebsch J, Hermundson J, Levine C, Swensen L. Severe premature coronary artery disease with protease inhibitors. Lancet. 1998; 351: 1328.
-
(1998)
Lancet
, vol.351
, pp. 1328
-
-
Henry, K.1
Melroe, H.2
Huebsch, J.3
Hermundson, J.4
Levine, C.5
Swensen, L.6
-
9
-
-
20944447671
-
Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy
-
Chaparro J , Reeds D, Wen W, Xueping E, Klein S, Semenkovich C, et al. Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy. Metabolism. 2005; 54: 561-7.
-
(2005)
Metabolism
, vol.54
, pp. 561-567
-
-
Chaparro, J.1
Reeds, D.2
Wen, W.3
Xueping, E.4
Klein, S.5
Semenkovich, C.6
-
10
-
-
0842291596
-
Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice
-
Xu A, Yin S, Wong L, Chan KW. Adiponectin ameliorates dyslipidemia induced by the human immunodeficiency virus protease inhibitor ritonavir in mice. Endocrinology. 2004; 145: 487-94.
-
(2004)
Endocrinology
, vol.145
, pp. 487-494
-
-
Xu, A.1
Yin, S.2
Wong, L.3
Chan, K.W.4
-
11
-
-
33748209571
-
Endothelial function in HIV-infected patients with low or mild cardiovascular risk
-
Blanco JJ, Garcia IS, Cerezo JG, Rivera JM, Anaya PM, Raya PG, et al. Endothelial function in HIV-infected patients with low or mild cardiovascular risk. J Antimicrob Chemother. 2006; 58: 133-9.
-
(2006)
J Antimicrob Chemother
, vol.58
, pp. 133-139
-
-
Blanco, J.J.1
Garcia, I.S.2
Cerezo, J.G.3
Rivera, J.M.4
Anaya, P.M.5
Raya, P.G.6
-
12
-
-
0037116573
-
Guidelines for the ultrasound assessment of endothelialdependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force
-
Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelialdependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002; 39: 257-65.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 257-265
-
-
Corretti, M.C.1
Anderson, T.J.2
Benjamin, E.J.3
Celermajer, D.4
Charbonneau, F.5
Creager, M.A.6
-
13
-
-
0242636456
-
Endothelial function in HIV infected patients receiving protease inhibitor therapy: Does immune competence affect cardiovascular risk?
-
Nolan D, Watts GF, Herrmann SE, French MA, Jonh M, Mallal S. Endothelial function in HIV infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk? QJM. 2003; 96: 825-32.
-
(2003)
QJM
, vol.96
, pp. 825-832
-
-
Nolan, D.1
Watts, G.F.2
Herrmann, S.E.3
French, M.A.4
Jonh, M.5
Mallal, S.6
-
14
-
-
0035902493
-
Use of human immunodeficiency virus - 1 protease inhibitors in associated with atherogenic lipoprotein changes and endothelial dysfunction
-
Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, et al. Use of human immunodeficiency virus - 1 protease inhibitors in associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation. 2001; 104: 257-62.
-
(2001)
Circulation
, vol.104
, pp. 257-262
-
-
Stein, J.H.1
Klein, M.A.2
Bellehumeur, J.L.3
McBride, P.E.4
Wiebe, D.A.5
Otvos, J.D.6
-
15
-
-
0041910147
-
Interaction of hypertension and diabetes on impairment of endothelial function
-
Ma L, Zhao S, Li J, Zhou Q, Gao M. Interaction of hypertension and diabetes on impairment of endothelial function. Chin Med J (Engl). 2001; 114 (6): 563-7.
-
(2001)
Chin Med J (Engl)
, vol.114
, Issue.6
, pp. 563-567
-
-
Ma, L.1
Zhao, S.2
Li, J.3
Zhou, Q.4
Gao, M.5
-
16
-
-
0032535699
-
Endothelium-dependent flow mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease
-
Takase B, Uehata A, Akima T, Nagai T, Nishioca T, Hamabe A, et al. Endothelium-dependent flow mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol. 1998; 82: 1535-9.
-
(1998)
Am J Cardiol
, vol.82
, pp. 1535-1539
-
-
Takase, B.1
Uehata, A.2
Akima, T.3
Nagai, T.4
Nishioca, T.5
Hamabe, A.6
-
17
-
-
6044223547
-
Clinical aspects of endothelial dysfunction associated with human immunodeficiency virus infection and antiretroviral agents
-
Shankar SS, Dube MP. Clinical aspects of endothelial dysfunction associated with human immunodeficiency virus infection and antiretroviral agents. Cardiovasc Toxicol. 2004; 4: 261-9.
-
(2004)
Cardiovasc Toxicol
, vol.4
, pp. 261-269
-
-
Shankar, S.S.1
Dube, M.P.2
-
18
-
-
32944477913
-
Vascular nitric oxide and oxidative stress: Determinants of endothelial adaptations to cardiovascular disease and to physical activity
-
Rush JW, Denniss SG, Graham DA. Vascular nitric oxide and oxidative stress: determinants of endothelial adaptations to cardiovascular disease and to physical activity. Can J Appl Physiol. 2005; 30 : 442-74.
-
(2005)
Can J Appl Physiol
, vol.30
, pp. 442-474
-
-
Rush, J.W.1
Denniss, S.G.2
Graham, D.A.3
-
19
-
-
6044220126
-
HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells
-
Mondal D, Pradhan L, Ali M, Agrawal KC. HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells. Cardiovasc Toxicol. 2004; 4: 287-302.
-
(2004)
Cardiovasc Toxicol
, vol.4
, pp. 287-302
-
-
Mondal, D.1
Pradhan, L.2
Ali, M.3
Agrawal, K.C.4
-
20
-
-
0037076029
-
Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients
-
Côté H, Brumme ZL, Craib K, Alexander CS, Wynhoven B, Wong H, et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med. 2002; 346: 811-20.
-
(2002)
N Engl J Med
, vol.346
, pp. 811-820
-
-
Côté, H.1
Brumme, Z.L.2
Craib, K.3
Alexander, C.S.4
Wynhoven, B.5
Wong, H.6
-
21
-
-
34247155694
-
Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction
-
Wang X, Chai H, Yao Q, Chen C. Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction. J Acquir Immune Defic Syndr. 2007; 44: 493-9.
-
(2007)
J Acquir Immune Defic Syndr
, vol.44
, pp. 493-499
-
-
Wang, X.1
Chai, H.2
Yao, Q.3
Chen, C.4
-
22
-
-
19344375240
-
Ginsenosides block HIV protease inhibitor ritonavir-induced vascular dysfunction of porcine coronary arteries
-
Chai H, Zhou W, Lin P, Lumsden A, Yao Q, Chen C. Ginsenosides block HIV protease inhibitor ritonavir-induced vascular dysfunction of porcine coronary arteries. Am J Physiol Heart Circ Physiol. 2005; 288: H2965 - H2971.
-
(2005)
Am J Physiol Heart Circ Physiol
, vol.288
-
-
Chai, H.1
Zhou, W.2
Lin, P.3
Lumsden, A.4
Yao, Q.5
Chen, C.6
-
23
-
-
19744369696
-
Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries
-
Chai H, Yan S, Peter L, Alan BL, Yao Q, Chen C. Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries. J Am Coll Surg. 2005; 200: 820-30.
-
(2005)
J Am Coll Surg
, vol.200
, pp. 820-830
-
-
Chai, H.1
Yan, S.2
Peter, L.3
Alan, B.L.4
Yao, Q.5
Chen, C.6
-
24
-
-
0032566847
-
HIV envelope protein gp120 induces neuropeptide y receptor-mediated proliferation of vascular smooth muscle cells: Relevance to AIDS cardiovascular pathogenesis
-
Kim J, Ruff M, Karwatowska-Prokopczuk E, Hunt L, Ji H, Pert CB, et al. HIV envelope protein gp120 induces neuropeptide y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis. Regul Pept. 1998; 75-76: 201-5.
-
(1998)
Regul Pept
-
-
Kim, J.1
Ruff, M.2
Karwatowska-Prokopczuk, E.3
Hunt, L.4
Ji, H.5
Pert, C.B.6
-
25
-
-
0030606730
-
Pneumocystis pneumonia, Los Angeles. 1981
-
Center for Disease Control and Prevention CDC
-
Center for Disease Control and Prevention (CDC). Pneumocystis pneumonia, Los Angeles. 1981. MMWR Morb Mortal Wkly Rep. 1996; 45 (34): 729-33.
-
(1996)
MMWR Morb Mortal Wkly Rep
, vol.45
, Issue.34
, pp. 729-733
-
-
|